Analyst firms · BNP Paribas Exane · VC

BNP Paribas Exane VC price target and rating history

Visteon Corporation (VC) · Consumer Discretionary

BNP Paribas Exane rates Visteon Corporation (VC) Neutral with a $130 price target, as of its latest action on Dec 13, 2023. It has published 3 rating actions on VC since April 2022, including 1 upgrade and 1 downgrade. Across 3 firms with a VC price target in the last 12 months, the median target is $135.

Current rating
Neutral
Price target
$130
Median target, all firms
$135
Actions on VC
3

BNP Paribas Exane price target on VC

$133$116$992023202420252026
BNP Paribas Exane price target on VC, each point a stated target, April 2022 to December 2023.

Every BNP Paribas Exane rating on VC

How other firms rate VC

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wolfe ResearchPeer Perform$135Jul 28, 2026
Robert W. BairdNeutral$121Jun 26, 2026
BarclaysOverweight$145Jun 22, 2026

Questions about BNP Paribas Exane and VC

What is BNP Paribas Exane's price target for VC?
BNP Paribas Exane's latest stated price target for Visteon Corporation (VC) is $130, from its action on Dec 13, 2023.
What is BNP Paribas Exane's rating on VC?
BNP Paribas Exane rates VC Neutral, a neutral rating, as of Dec 13, 2023.
When did BNP Paribas Exane last change its view on VC?
On Dec 13, 2023, BNP Paribas Exane downgrades to Neutral from Outperform, price target $130.
How does BNP Paribas Exane's VC target compare with other analysts?
Across 3 firms with a VC price target in the last 12 months, the median target is $135.

More VC rating histories

All BNP Paribas Exane ratingsVC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.